Approval · Notice of Compliance 159 · 2004
RAMACE: Notice of Compliance 159
Issued January 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 159
- Date
- January 15, 2004
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New dosage form
- Therapeutic class
- Angiotensin converting enzyme inhibitor